Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
South Dakota Governor Daugaard Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicines
February 9, 2018
Washington, D.C. (February 09, 2018) – The Biotechnology Innovation Organization (BIO) and the South Dakota Biotech Association commend Governor Dennis Daugaard for signing critical legislation to create a pathway for the substitution of…
BIO Statement on Medicare Part D Changes in Budget Deal
February 8, 2018
Washington, DC (February 8, 2018) – BIO President and CEO Jim Greenwood issued the following statement today regarding proposed changes to the Medicare Part D program in the announced budget deal.
BIO Statement on U.S. Falling to 12th Ranking of International Patent System Strength
February 8, 2018
The steady decline of America as an innovation-supporting economy is due to an unbalanced patent challenge system.  
BIO’s Statement on the Confirmation of Andrei Iancu to Lead the U.S. Patent and Trademark Office
February 5, 2018
Washington, D.C. (February 5, 2018) – The following statement may be attributed to BIO President & CEO James Greenwood:“I congratulate Andrei Iancu on his Senate confirmation to fill the position of Under Secretary of Commerce for Intellectual…
BIO Applauds USDA-FDA Agreement to Improve Coordination
January 30, 2018
Washington, D.C. (January 30, 2018) – The Biotechnology Innovation Organization (BIO) is applauding a new agreement announced by the U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA) to enhance coordination between the…
BIO Congratulates Alex Azar on Confirmation as Secretary of Health and Human Services
January 24, 2018
BIO Congratulates Alex Azar on Confirmation asSecretary of Health and Human Services Washington, DC (January 24, 2018) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding…
BIO Releases First Report in a Series on the State of Innovation in Highly Prevalent Chronic Diseases
January 18, 2018
First-of-its-kind report highlights the need to stimulate development efforts for depression therapeutics. Washington, DC (January 18, 2018) – Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of…
BIO Statement on House Energy & Commerce Committee 340B Drug Pricing Program Review
January 10, 2018
Washington, DC (January 10, 2018) – BIO President and CEO Jim Greenwood issued the following statement regarding the review of the 340B drug pricing program released by the House Energy & Commerce Committee today:
BIO Applauds Support for Innovation in Trump Administration Task Force Report
January 9, 2018
“Biotechnology Sector is a Driver of the ‘Fourth Industrial Revolution’”Washington, D.C. (January 9, 2018) – The Biotechnology Innovation Organization (BIO) is applauding a new report from the Interagency Task Force on Agriculture and Rural…
BIO Statement on Retirement of Senator Orrin Hatch
January 2, 2018
Washington, DC (January 2, 2018) – “BIO joins the nation – and the great state of Utah – in applauding Senator Hatch for his many years of service, and for proving time and time again to be a strong champion for biomedical innovation."